Meet the team

Linda Pullan, PhD
President, Pullan Consulting

Dr. Linda Pullan has over 20 years of drug industry experience, beginning in drug discovery at Monsanto/Searle (now Pfizer) and ICI/Zeneca (now AstraZeneca). She contributed to and led teams that put the multibillion-dollar antipsychotic Seroquel and other molecules into development. Her business development experiences began with in-licensing technology and early drug candidates in all therapeutic areas at what is now AstraZeneca, and continued with her role as head of oncology and hematology licensing for Amgen. She then joined Kosan Biosciences as VP of Business Development and experienced all the tasks of out-licensing and business development in a small company. She has also served as President and CEO of Viriome Inc, and she serves on the board of directors of Paloma Pharmaceuticals.

For several years, Dr. Pullan has been providing companies help in identification, evaluation, valuation, negotiation and strategy for partnering in or out. She has an extensive deal sheet ranging from company acquisitions to Phase III compounds, from preclinical candidates to technologies.

She writes a free monthly newsletter with tidbits of science and business, Pullan’s Pieces. It has a circulation of more than 4,000.

Dr. Pullan has a PhD in biochemistry from the University of California, Riverside, and a BS in chemistry from the University of Utah.